IRCI Gynae Sarcomas, High Grade Uterine Sarcoma

NCT01979393 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

NETWORK

Sponsor class

Conditions

Uterine Sarcoma

Interventions

DRUG: Cabozantinib
DRUG: Placebo

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]